In stage 0 PC, the positivity rates of the apoA2-i Index and CA19-9 were 66.7% and 33.3%, respectively, in cases of IPMN with high-grade dysplasia, while both were negative in cases of HG-PanIN. The gene discussed is APOA2; the disease is pancreatic intraductal papillary-mucinous neoplasm.